Kintara Therapeutics Stock Quote KTRA - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.1332

Bid

0.133

Ask

0.1332

Volume

7,678,446

0.111 Day's Range 0.1433

0.081 52 Week Range 5.98

Market Cap

5.075M

Previous Close

0.1143

Open

0.1141

Last Trade

500

0.1332

(formt)

Last Trade Time

Financial Volume

$ 991,939

VWAP

0.129185

Average Volume (3m)

14,489,155

Shares Outstanding

39,037,899

Dividend Yield

PE Ratio

-0.34

Earnings Per Share (EPS)

-0.38

Revenue

Net Profit

-15.02M

Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and ... Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kintara.com

Headquarters

Reno, Nevada, USA

Founded

1970

Kintara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KTRA. The last closing price for Kintara Therapeutics was $0.11. Over the last year, Kintara Therapeutics shares have traded in a share price range of $ 0.081 to $ 5.98.

Kintara Therapeutics currently has 39,037,899 shares outstanding. The market capitalization of Kintara Therapeutics is $5.07 million. Kintara Therapeutics has a price to earnings ratio (PE ratio) of -0.34.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0236	21.5328467153	0.1096	0.1433	0.101	3118102	0.11434295	CS
4	0.0435	48.4949832776	0.0897	0.24	0.086	18122618	0.14835434	CS
12	0.0092	7.41935483871	0.124	0.24	0.081	14489155	0.12544878	CS
26	-4.0168	-96.7903614458	4.15	4.48	0.081	9654953	0.14446364	CS
52	-3.1368	-95.9266055046	3.27	5.98	0.081	4896883	0.18488875	CS
156	-70.3668	-99.8110638298	70.5	142.5	0.081	2673931	10.56984345	CS
260	-60.3668	-99.7798347107	60.5	167.5	0.081	2300681	15.08004973	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NIVFNewGenIvf Group Ltd	$ 2.23 (74.22%)	137.08M
MTCMMTec Inc	$ 2.24 (43.59%)	6.07M
OPRTOportun Financial Corporation	$ 3.16 (40.44%)	11.71M
SHIMShimmick Corporation	$ 3.05 (35.56%)	1.19M
HKITHitek Global Inc	$ 1.35 (32.35%)	411.78k
ABEOAbeona Therapeutics Inc	$ 3.39 (-53.94%)	5.51M
GWAVGreenwave Technology Solutions Inc	$ 0.0696 (-44.89%)	37.05M
LICNLichen China Limited	$ 0.56 (-42.19%)	6.61M
MLECMoolec Science SA	$ 1.71 (-30.77%)	3.16M
VAXXVaxxinity Inc	$ 0.1971 (-26.89%)	2.11M
CYNCYNGN Inc	$ 0.113 (-6.61%)	326.58M
PEGYPineapple Energy Inc	$ 0.0561 (22.49%)	185.74M
SQQQProShares UltraPro Short QQQ	$ 11.91 (-4.49%)	139.15M
NIVFNewGenIvf Group Ltd	$ 2.23 (74.22%)	137.08M
TSLATesla Inc	$ 144.68 (1.85%)	124.55M